medicalxpress.com
A groundbreaking AI-integrated endoscope could revolutionize cancer surgery by allowing real-time tumor identification and removal, enhancing surgical precision and patient outcomes.
This development is significant as it represents a technological leap in surgical oncology, potentially reducing recovery times and the need for follow-up surgeries, resulting in better patient outcomes.
A research team in Germany has developed an AI-integrated endoscope that uses AI and laser technology to identify and remove tumor tissue in real time. Published in Science Advances, this technology allows precise differentiation of tumor boundaries without dyes, offering a new 'see and treat' approach. It has been tested on tissue samples from 15 patients, showing 96% accuracy in tumor identification. The next phase involves clinical trials, with goals to standardize this method for broader medical applications.
AI technology can significantly improve surgery outcomes by providing precise real-time data. The combination of AI with optical imaging enhances the accuracy of tumor identification.
AI processes complex imaging data quickly, which assists surgeons in making informed decisions during operations. Through deducing from the fact that AI has processed complex data accurately in multiple cases, surgeons can rely on its findings for better outcomes.
The integration of various optical imaging methods through multimodal approaches enables the endoscope to analyze chemical and structural tissue properties in real time. This capability significantly enhances the precision of identifying tumor boundaries. The AI component then processes the gathered imaging data rapidly, aiding surgeons in making immediate, informed decisions.
Prof. Dr. Jürgen Popp emphasized, "This allows us to identify tumor boundaries with high precision."
The 'see and treat' approach streamlines surgical procedures by combining diagnosis and treatment in one operation. The innovation allows simultaneous diagnosis and removal of tumors, reducing the need for multiple surgeries. This integration minimizes patient trauma and potentially improves recovery times by decreasing surgical invasiveness.
By integrating diagnosis with therapy, immediate actions during surgery reduce the necessity of additional procedures, leading to quicker patient recovery and less trauma. The novel endoscope features a femtosecond laser that allows surgeons to excise tumor tissue precisely while preserving healthy tissue. This is part of its dual capability, merging diagnosis and therapy in one device, an advancement that improves surgical outcomes and patient safety.
Prof. Dr. Orlando Guntinas-Lichius stated, "The 'see and treat' principle is a significant advancement, as it makes surgery safer and improves patients' chances of recovery."
Expanding the use of AI-integrated endoscopic technology can benefit various medical fields beyond oncology. There is potential for this technology to apply to other surgical areas, given its accuracy and efficiency.
Success in preclinical studies indicates a promising future for broader medical applications, such as in dermatology or neurosurgery. From the positive results in a specific application, one can inductively infer its potential success in other areas where precision is crucial.
With the technology currently undergoing clinical trials, researchers are optimistic about its application in other medical fields beyond oncology. The high precision and accuracy demonstrated in preclinical studies suggest that similar approaches could be beneficial in specialties such as dermatology and neurosurgery.
Prof. Popp remarked, "Our goal is to make this light-based method a standard tool in cancer surgery within the next few years."
Calvarese, M., et al. (2024). Endomicroscopic AI-driven morphochemical imaging and fs-laser ablation for selective tumor identification and selective tissue removal. Science Advances, 10(50), eado9721. DOI: 10.1126/sciadv.ado9721